Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Operating Leases (2019 - 2025)

Historic Operating Leases for Dentsply Sirona (XRAY) over the last 7 years, with Q3 2025 value amounting to $85.0 million.

  • Dentsply Sirona's Operating Leases fell 1747.57% to $85.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.0 million, marking a year-over-year decrease of 1747.57%. This contributed to the annual value of $91.0 million for FY2024, which is 2720.0% down from last year.
  • As of Q3 2025, Dentsply Sirona's Operating Leases stood at $85.0 million, which was down 1747.57% from $92.0 million recorded in Q2 2025.
  • In the past 5 years, Dentsply Sirona's Operating Leases ranged from a high of $159.0 million in Q2 2022 and a low of $85.0 million during Q3 2025
  • Its 5-year average for Operating Leases is $126.8 million, with a median of $133.0 million in 2023.
  • Its Operating Leases has fluctuated over the past 5 years, first surged by 3762.38% in 2021, then tumbled by 2720.0% in 2024.
  • Quarter analysis of 5 years shows Dentsply Sirona's Operating Leases stood at $149.0 million in 2021, then changed by 0.0% to $149.0 million in 2022, then fell by 16.11% to $125.0 million in 2023, then fell by 27.2% to $91.0 million in 2024, then decreased by 6.59% to $85.0 million in 2025.
  • Its Operating Leases stands at $85.0 million for Q3 2025, versus $92.0 million for Q2 2025 and $88.0 million for Q1 2025.